*IMBRUVICA^® By Your Side patient support program is not intended to provide medical advice, replace prescribed treatment plans, or provide treatment or case management services. Patients are advised to talk to their healthcare provider and treatment team about any medical decisions and concerns they may have.

^†By Your Side Ambassadors are provided by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie Company, and do not work under the direction of your healthcare professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.

^‡Terms and Conditions Apply. This benefit covers IMBRUVICA^® (ibrutinib). Eligibility: Available to patients with commercial insurance coverage for IMBRUVICA^® who meet eligibility criteria. Copay assistance program is not available to patients receiving reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the IMBRUVICA^® Copay Card and patient must call the IMBRUVICA^® Copay Card Program at 1-855-332-6210 to stop participation.

The copay assistance program is subject to a maximum annual benefit on a calendar year basis, and other restrictions, including monthly maximums, may apply. Call the IMBRUVICA^® Copay Card Program at 1-855-332-6210 for additional information about potential restrictions, including maximums on assistance, that may apply. The actual application and use of the benefit available under the copay assistance program may vary on a monthly, quarterly, and/or annual basis depending on each individual patient’s plan of insurance and other prescription drug costs. This copay assistance program is subject to change, reduction or discontinuation in monetary amount/maximum annual benefit, or discontinuation without any notice. Except where prohibited by applicable law, this includes potential reduction or discontinuation to ensure that copay assistance is utilized solely for the patient’s benefit. Patients may not seek reimbursement for value received from the IMBRUVICA^® Copay Program from any third-party payers.

This assistance offer is not health insurance. By utilizing this copay assistance program, you hereby accept and agree to abide by these terms and conditions. Any individual or entity who enrolls or assists in the enrollment of a patient in the copay assistance program represents that the patient meets the eligibility criteria and other requirements described herein. Further, you agree that you currently meet the eligibility criteria and other requirements described herein every time you use the copay assistance program. For information on how we collect and process your personal data, including the categories we collect, purposes for their collection, and disclosures to third parties, visit https://www.pharmacyclics.com/privacy-notice.html#info_pcp